GlassScriptPhysician profile
Hekmat Hakiman
NPI 1518129055
$56,895.94
in general payments reported to CMS, 2019-2025
35 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $3,396 · 2021: $19K · 2022: $4,811 · 2023: $808 · 2024: $6,322 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $2,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $2,292.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $53,013.86 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $878.36 | 2021-2025 | Interstim |
| Ethicon US, LLC | $517.15 | 2020-2025 | Harmonic, Echelon Circular, Echelon Flex |
| Zyla Life Sciences, INC. | $279.42 | 2019-2020 | |
| Coloplast Corp | $269.91 | 2019-2023 | Sensura Mio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $206.65 | 2019-2024 | Plenvu, Xifaxan |
| Stryker Corporation | $179.88 | 2019-2023 | Spy-Phi System |
| Vertex Pharmaceuticals Incorporated | $172.68 | 2024-2025 | |
| Mallinckrodt Enterprises LLC | $150.78 | 2019 | |
| Smith+Nephew, INC. | $131.64 | 2023-2025 | Stravix Pl, Stravix, Grafix |
| Braintree Laboratories, INC. | $128.88 | 2019-2024 | Suflave, Sutab |
| Baxter Healthcare | $126.51 | 2022-2023 | |
| Abbott Laboratories | $107.34 | 2023 | Proclaim |
| Tempus Ai, INC | $82.77 | 2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $75.41 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $52.92 | 2024-2025 | Solesta |
| Virtual Incision Corporation | $40.41 | 2025 | Mira |
| Axonics, INC. | $38.75 | 2022 | |
| Palette Life Sciences, INC. | $37.76 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $37.61 | 2022-2025 | Exparel |
| Baudax Bio INC. | $35.61 | 2020 | |
| Kci USA, INC. | $35.51 | 2019-2020 | |
| Shire North American Group INC | $34.12 | 2019 | |
| Acacia Pharma INC | $29.30 | 2021 | |
| Boston Scientific Corporation | $28.90 | 2025 | Bulkamid |
| Monaghan Medical Corporation | $28.46 | 2023 | Aerobika, Aeroeclipse |
| Takeda Pharmaceuticals U.S.A., INC. | $27.70 | 2020-2021 | |
| Acell, INC. | $24.74 | 2020 | |
| Heron Therapeutics, INC. | $23.18 | 2022 | |
| Hologic Sales and Service, LLC | $20.86 | 2025 | Coolseal Generator |
| Mimedx Group, INC. | $18.27 | 2025 | |
| Allergan, INC. | $16.18 | 2021 | |
| Covidien LP | $15.53 | 2019 | |
| Innocoll Pharmaceuticals Limited | $14.68 | 2021 | |
| Advanced Oxygen Therapy INC. | $14.21 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hekmat Hakiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.